Effect of intravenous propranolol or verapamil on infant orthodromic reciprocating tachycardia

Gary (Michael) Silberbach, Ann Dunnigan, D. Woodrow Benson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effects of intravenous verapamil (0.15 mg/kg) and propranolol (0.2 mg/kg) with regard to atrioventricular (AV) conduction and tachycardia termination during paroxysmal atrial tachycardia were compared in 2 groups of infants (verapamil n = 14, propranolol n = 18, mean age 80 ± 21 days, range 1 to 364). Using transesophageal recording techniques, tachycardia cycle length, AV intervals and ventriculoatrial intervals were measured before and after drug administration. Both intravenous propranolol and verapamil significantly prolonged tachycardia cycle length and AV interval (cycle length-propranolol 230 ± 30 to 262 ± 33 ms, p

Original languageEnglish (US)
Pages (from-to)438-442
Number of pages5
JournalThe American Journal of Cardiology
Volume63
Issue number7
DOIs
StatePublished - Feb 15 1989
Externally publishedYes

Fingerprint

Reciprocating Tachycardia
Verapamil
Propranolol
Tachycardia
Paroxysmal Tachycardia
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of intravenous propranolol or verapamil on infant orthodromic reciprocating tachycardia. / Silberbach, Gary (Michael); Dunnigan, Ann; Benson, D. Woodrow.

In: The American Journal of Cardiology, Vol. 63, No. 7, 15.02.1989, p. 438-442.

Research output: Contribution to journalArticle

@article{f5e2d4f6a10546d4ae11f3ffb32b1479,
title = "Effect of intravenous propranolol or verapamil on infant orthodromic reciprocating tachycardia",
abstract = "The effects of intravenous verapamil (0.15 mg/kg) and propranolol (0.2 mg/kg) with regard to atrioventricular (AV) conduction and tachycardia termination during paroxysmal atrial tachycardia were compared in 2 groups of infants (verapamil n = 14, propranolol n = 18, mean age 80 ± 21 days, range 1 to 364). Using transesophageal recording techniques, tachycardia cycle length, AV intervals and ventriculoatrial intervals were measured before and after drug administration. Both intravenous propranolol and verapamil significantly prolonged tachycardia cycle length and AV interval (cycle length-propranolol 230 ± 30 to 262 ± 33 ms, p",
author = "Silberbach, {Gary (Michael)} and Ann Dunnigan and Benson, {D. Woodrow}",
year = "1989",
month = "2",
day = "15",
doi = "10.1016/0002-9149(89)90315-9",
language = "English (US)",
volume = "63",
pages = "438--442",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Effect of intravenous propranolol or verapamil on infant orthodromic reciprocating tachycardia

AU - Silberbach, Gary (Michael)

AU - Dunnigan, Ann

AU - Benson, D. Woodrow

PY - 1989/2/15

Y1 - 1989/2/15

N2 - The effects of intravenous verapamil (0.15 mg/kg) and propranolol (0.2 mg/kg) with regard to atrioventricular (AV) conduction and tachycardia termination during paroxysmal atrial tachycardia were compared in 2 groups of infants (verapamil n = 14, propranolol n = 18, mean age 80 ± 21 days, range 1 to 364). Using transesophageal recording techniques, tachycardia cycle length, AV intervals and ventriculoatrial intervals were measured before and after drug administration. Both intravenous propranolol and verapamil significantly prolonged tachycardia cycle length and AV interval (cycle length-propranolol 230 ± 30 to 262 ± 33 ms, p

AB - The effects of intravenous verapamil (0.15 mg/kg) and propranolol (0.2 mg/kg) with regard to atrioventricular (AV) conduction and tachycardia termination during paroxysmal atrial tachycardia were compared in 2 groups of infants (verapamil n = 14, propranolol n = 18, mean age 80 ± 21 days, range 1 to 364). Using transesophageal recording techniques, tachycardia cycle length, AV intervals and ventriculoatrial intervals were measured before and after drug administration. Both intravenous propranolol and verapamil significantly prolonged tachycardia cycle length and AV interval (cycle length-propranolol 230 ± 30 to 262 ± 33 ms, p

UR - http://www.scopus.com/inward/record.url?scp=0024510813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024510813&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(89)90315-9

DO - 10.1016/0002-9149(89)90315-9

M3 - Article

C2 - 2916428

AN - SCOPUS:0024510813

VL - 63

SP - 438

EP - 442

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -